Skip to content

Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder

Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03095170
Acronym
PEACEOFMND
Enrollment
5
Registered
2017-03-29
Start date
2017-03-23
Completion date
2022-03-21
Last updated
2022-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amnestic Disorder, Dementia and Amnestic Conditions, Impaired Cognition, Memory Disorders, Memory Impairment, Mild Cognitive Disorder, Mild Cognitive Impairment, Mild Dementia, Mild Neurocognitive Disorder, Poor Short-term Memory

Brief summary

Behavioral interventions currently provide the most useful approach to addressing the behavioral and social needs of those with Mild Cognitive Impairment (MCI) due to Alzheimer's or other diseases. This randomized, multisite, 3-arm study will investigate the impact of computerized brain fitness vs yoga vs an active control group (wellness education) on changes in cognitive function, daily functioning and quality of life in persons with Mild Cognitive Impairment (MCI) and their partner. In addition, in vivo neuroimaging measures of plasticity during the pre- and post-intervention periods will be measured and compared between the three different treatment groups. These neuroimaging measures of plasticity will be investigated in their relationship to the cognitive outcomes within each group.

Interventions

BEHAVIORALComputerized brain fitness training

Will use the commercially available Posit Science product BrainHQ™ (www.brainhq.com) on tablets (e.g. iPads). Participants will complete 45-60 minutes of training daily in the program.

BEHAVIORALYoga

Will use adapted Hatha Yoga where participants sit on armless chairs placed on sticky mats for some asana (poses) and use the chair for support throughout. This adapted Hatha Yoga style is appropriate for older adults including those who have limited mobility, use walkers or are in wheelchairs. The appropriately sequenced yoga practice meets the American College of Sports Medicine recommendation for older adults for muscle strengthening and flexibility. Instructions are modeled for the participants

The education component will involve daily 60-minute group sessions with topics such as Introduction to the Program, Living with MCI, Changes in Roles, Communication and Relationships, Sleep Hygiene, Steps to Healthy Brain Aging, Preventing Dementia, MCI and Depression, Nutrition, Safety and Assistive Technologies, and Participating in Research, Community Resources, Meaning and Purpose, and Joy.

Journal© as a basis for reminiscence-focused group sessions. Partner: The care partner support group meets separately from the patient group for 45-60 minutes daily.

BEHAVIORALCognitive Rehabilitation

Will provide each couple with memory compensation training 5 days per week for 2 weeks, with initial and ending adherence sessions. All sessions will involve 45- 60 minutes of training. The curriculum is described briefly here. Learning phases. three training stages from learning theory: 1) an acquisition phase in which use of the memory compensation system is learned, 2) an application phase in which a participant is taught to apply to his/her daily life, and 3) an adaptation phase in which a participant practices incorporating into his/her daily life so as to make its use habitual.

Sponsors

Mayo Clinic
CollaboratorOTHER
Tallahassee Memorial HealthCare
CollaboratorOTHER
Florida Department of Health
CollaboratorOTHER_GOV
University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

For the patients diagnosed with MCI: Inclusion Criteria: 1. Written informed consent for participation. Patient also needs to sign a legally authorized representative (LAR) addendum should MCI patient become incapacitated 2. A diagnosis of amnestic MCI (single domain or multi-domain) 3. A Clinical Dementia Rating scale score of 0 or 0.5 4. At least 50. 5. Either not taking or stable on nootropic(s) and/or pain medication for at least 3 months. 6. Fluent in English. 7. A score of at least 25 on the Telephone Interview for Cognitive Status for Memory.

Exclusion criteria

1. MRI contraindications (e.g., ferrous metal in the body, claustrophobia, pregnancy) 2. Physical impairments, language comprehension deficits, or significant hearing disturbances that would limit ability to perform tasks or participation in the intervention. For the care partners: Inclusion Criteria: 1. Written informed consent for participation. 2. At least 21 years of age. 3. A score of at least 32 on the Telephone Interview for Cognitive Status for Memory. 4. Partner has at least twice-weekly contact with the participant.

Design outcomes

Primary

MeasureTime frameDescription
Resting State Magnetic Resonance Imaging (MRI)baseline to 7.5 monthsResting State MRI will allow us to investigate the functional connectivity in the brain, by looking at resting state networks such as the Default Mode Network.

Secondary

MeasureTime frameDescription
Diffusion Tensor Imaging (DTI)baseline to 7.5 MonthsDTI will be used to map white matter tractography in the brain.

Other

MeasureTime frameDescription
improvement in patient memory based everyday functioningbaseline to 7.5 Monthsmeasured by the Everyday Cognitive Functioning scale (ECOG)
improvement in patient and care partner quality of lifebaseline to 7.5 Monthsmeasured by the quality of life measured by the Quality of Life in Alzheimer's Disease scale (QOL-AD)
improvement in patient and carepartner moodbaseline to 7.5 Monthsmeasured by the Center for Epidemiological Studies-Depression (CESD)
improvement in patient cognitive functioningbaseline to 7.5 Monthsmeasured by the CogState

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026